AR040889A1 - Agonistas muscarinicos - Google Patents
Agonistas muscarinicosInfo
- Publication number
- AR040889A1 AR040889A1 AR20030103011A ARP030103011A AR040889A1 AR 040889 A1 AR040889 A1 AR 040889A1 AR 20030103011 A AR20030103011 A AR 20030103011A AR P030103011 A ARP030103011 A AR P030103011A AR 040889 A1 AR040889 A1 AR 040889A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedures
- manufacture
- useful
- muscarinic agonists
- muscarnic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Proporciona hemidrato cristalino de (R)-(6-(1_((4-fluorobencil)metilamino)etilidenoamino)-2-(R)-hidroxiindan-1-il)amida del ácido bifenil-4-carboxílico, composicciones del mismo, procedimientos de uso del mismo, procedimientos para la fabricación del mismo y procedimientos para la fabricación de intermedios del mismo. Utiles como agonistas selectivo del receptor M-1 muscarnico y de esta manera útil para trastornos del sistema nervioso central.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40544302P | 2002-08-22 | 2002-08-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR040889A1 true AR040889A1 (es) | 2005-04-20 |
Family
ID=31946873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR20030103011A AR040889A1 (es) | 2002-08-22 | 2003-08-20 | Agonistas muscarinicos |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7160922B2 (es) |
| EP (1) | EP1534667B1 (es) |
| JP (1) | JP4469280B2 (es) |
| CN (1) | CN100554247C (es) |
| AR (1) | AR040889A1 (es) |
| AT (1) | ATE491683T1 (es) |
| AU (1) | AU2003256791B2 (es) |
| BR (1) | BR0313161A (es) |
| CA (1) | CA2493958C (es) |
| CY (1) | CY1111115T1 (es) |
| DE (1) | DE60335380D1 (es) |
| DK (1) | DK1534667T3 (es) |
| ES (1) | ES2355213T3 (es) |
| MX (1) | MXPA05002080A (es) |
| PE (1) | PE20040894A1 (es) |
| PT (1) | PT1534667E (es) |
| SI (1) | SI1534667T1 (es) |
| TW (1) | TW200410922A (es) |
| WO (1) | WO2004018411A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2275095A3 (en) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| JP2013523679A (ja) | 2010-03-29 | 2013-06-17 | ビーエーエスエフ ソシエタス・ヨーロピア | 殺菌性イミノ誘導体 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20040053130A (ko) * | 2001-09-21 | 2004-06-23 | 일라이 릴리 앤드 캄파니 | 무스카린성 효능제 |
-
2003
- 2003-08-12 BR BR0313161-0A patent/BR0313161A/pt not_active IP Right Cessation
- 2003-08-12 ES ES03792989T patent/ES2355213T3/es not_active Expired - Lifetime
- 2003-08-12 CN CNB038192500A patent/CN100554247C/zh not_active Expired - Fee Related
- 2003-08-12 WO PCT/US2003/023260 patent/WO2004018411A1/en active Application Filing
- 2003-08-12 DK DK03792989.0T patent/DK1534667T3/da active
- 2003-08-12 EP EP03792989A patent/EP1534667B1/en not_active Expired - Lifetime
- 2003-08-12 PT PT03792989T patent/PT1534667E/pt unknown
- 2003-08-12 US US10/524,960 patent/US7160922B2/en not_active Expired - Fee Related
- 2003-08-12 AU AU2003256791A patent/AU2003256791B2/en not_active Ceased
- 2003-08-12 SI SI200331933T patent/SI1534667T1/sl unknown
- 2003-08-12 CA CA2493958A patent/CA2493958C/en not_active Expired - Fee Related
- 2003-08-12 DE DE60335380T patent/DE60335380D1/de not_active Expired - Lifetime
- 2003-08-12 AT AT03792989T patent/ATE491683T1/de active
- 2003-08-12 MX MXPA05002080A patent/MXPA05002080A/es active IP Right Grant
- 2003-08-12 JP JP2004530846A patent/JP4469280B2/ja not_active Expired - Fee Related
- 2003-08-20 TW TW092122893A patent/TW200410922A/zh unknown
- 2003-08-20 AR AR20030103011A patent/AR040889A1/es unknown
- 2003-08-21 PE PE2003000851A patent/PE20040894A1/es not_active Application Discontinuation
-
2011
- 2011-01-19 CY CY20111100057T patent/CY1111115T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004018411A1 (en) | 2004-03-04 |
| MXPA05002080A (es) | 2005-08-18 |
| EP1534667B1 (en) | 2010-12-15 |
| BR0313161A (pt) | 2005-06-14 |
| CY1111115T1 (el) | 2015-06-11 |
| TW200410922A (en) | 2004-07-01 |
| JP4469280B2 (ja) | 2010-05-26 |
| ATE491683T1 (de) | 2011-01-15 |
| AU2003256791B2 (en) | 2008-12-11 |
| CA2493958A1 (en) | 2004-03-04 |
| JP2005536549A (ja) | 2005-12-02 |
| PT1534667E (pt) | 2011-01-19 |
| ES2355213T3 (es) | 2011-03-23 |
| DE60335380D1 (de) | 2011-01-27 |
| US7160922B2 (en) | 2007-01-09 |
| SI1534667T1 (sl) | 2011-02-28 |
| CN1675173A (zh) | 2005-09-28 |
| EP1534667A1 (en) | 2005-06-01 |
| DK1534667T3 (da) | 2011-02-14 |
| US20060122280A1 (en) | 2006-06-08 |
| PE20040894A1 (es) | 2004-11-25 |
| AU2003256791A1 (en) | 2004-03-11 |
| CN100554247C (zh) | 2009-10-28 |
| CA2493958C (en) | 2010-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066391A (es) | [1,8] naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia | |
| CU23780B7 (es) | Compuestos de quinolina heteroaromaticos y su uso como inhibidores de pde10 | |
| BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
| DE60231868D1 (de) | Folat-mimetika und deren folatrezeptorbindende konjugate | |
| MX2007007220A (es) | Compuestos de pirazolona como agonistas de receptor de glutamato metabotropico para el tratamiento de trastornos neurologicos y psiquiatricos. | |
| AR055123A1 (es) | Asociacion de un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion larga y un agente hipnotico de duracion de accion corta, composicion farmaceutica que la contiene y su aplicacin en terapeutica | |
| TW200531679A (en) | Methods of modulating cytokine activity; related reagents | |
| ECSP055676A (es) | Piperazinas heterocíclicas sustituidas para el tratamiento de la esquizofrenia | |
| BR0208179A (pt) | Composto, composição farmacêutica, métodos para tratar distúrbios associados com o receptor 5-ht6, distúrbios cognitivos, distúrbios da mémoria, psicose, esquizofrenia, e ansiedade, e, uso de um composto | |
| BRPI0511695A (pt) | agonistas de receptor (beta)2 adrenérgico diamina | |
| BRPI0409173A (pt) | compostos e composições como inibidores de proteìna quinase | |
| BR0309875A (pt) | métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto | |
| TW200800959A (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor | |
| GT200500332A (es) | Azabenzoxazoles para el tratamiento de trastornos del snc | |
| PA8597301A1 (es) | Derivados de imidazol-4-il-etinil-piridina | |
| BRPI0414634A (pt) | agonistas de receptor b2, adrenérgico de etilamino amino-substituìdo | |
| DE60313004D1 (de) | Alpha-7-nikotinsäure-rezeptoragonisten und statine in kombination | |
| HN2002000365A (es) | Lactamas como antagonistas de taquiquininas | |
| BR0211561A (pt) | Compostos e composições de 5-arilsulfonil indóis tendo afinidade para receptor 5-ht6 e seus usos | |
| DOP2006000145A (es) | Derivados de pirido [20,3-d] pirimidina su preparación, aplicación en terapeútica . | |
| AR029428A1 (es) | DERIVADOS DE FENIL--PIPERIDINA, TETRAHIDROPIRIDINA,-PIPERAZINA,-AZEPAN,-TETRAHIDRO-1H-AZEPINA Y DIAZEPAN SUSTITUIDOS, UNA COMPOSICIoN FARMACEUTICA Y EL USO DE LOS MISMOS PARA LA MANUFACTURA DE UNA PREPARACION FARMACEUTICA | |
| CL2003001360A1 (es) | Compuestos derivados de pirazol, composicion farmaceutica, agonistas o antagonistas selectivos dl receptor cck-1, utiles para el tratamiento de trastornos gastrointestinales y del sistema nervioso central. | |
| AR040889A1 (es) | Agonistas muscarinicos | |
| AR056279A1 (es) | Derivados de aril 1,4- pirazina sustituidos, composicion farmaceutica y un metodo in vitro | |
| BRPI0804121A2 (pt) | métodos para a resolução de 4-[4-(dimetil-amino)-1-(4'-fluoro-fenil)-1-hidróxi-butil]-3 -(hidróxi-metil)-benzonitrila como uma mistura racêmica ou não-racêmica de enanciÈmeros em seus enanciÈmeros isolados e para a manufatura de escitalopram |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |